|Assessment process complete
|For haemodynamically stable, symptomatic patients with atrial fibrillation of less than 48 hours duration.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended
|Full submission received from Applicant
|NCPE assessment completed
|NCPE assessment outcome
|Reimbursement Recommended in Hospital Setting.
Following review, we recommend reimbursement of vernakalant in the hospital setting.